| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -5.6e-05 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -2.2e-05 | 1 |